<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02791165</url>
  </required_header>
  <id_info>
    <org_study_id>2015/3033</org_study_id>
    <nct_id>NCT02791165</nct_id>
  </id_info>
  <brief_title>Using Cardiac MRI to Characterise the Dynamic Changes Which Occur in the Acutely Reperfused STEMI Patient</brief_title>
  <official_title>Using Cardiac MRI to Characterise the Dynamic Changes Which Occur in the Acutely Reperfused STEMI Patient</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart Centre Singapore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Heart Centre Singapore</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is an optimal day on which to perform the CMR scan which allows one to capture the
      information required to assess the dynamic changes in the reperfused STEMI patient. The main
      objective is to characterise the dynamic changes in LV function, MI size, myocardial edema,
      MVO, IMH, interstitial volume in the remote myocardium over the first 10 days of an acute
      reperfused STEMI in order to identify the optimal day for performing the CMR scan.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a prospective observational study with serial CMR imaging only.

      CMR scan Each patient will receive one CMR scan performed on Day 1, Day 3, Day 5, Day 10
      following the PPCI procedure on a 3T Philips scanner (see study flow below). All CMR scans
      will be analysed at a central CMR corelab.

      For Day 1, 3, 5, 7 and 10 CMRs, parameters will be collected as follows:

        -  Left ventricle (LV) ejection fraction and indexed LV end systolic and diastolic volumes
           and mass using short-axis SSFP cine imaging and myocardial tagging sequences).

        -  The AAR by T1 and T2 mapping18 as a percentage of the LV over time.

        -  Signal intensity of T1 and T2 mapping in the MI zone, MI core and remote myocardium over
           time.

        -  The incidence of intramyocardial haemorrhage (IMH)(hypo-enhancement on T2* mapping
           sequence)26.

        -  The volume of microvascular obstruction (MVO) defined as signal intensity 2 standard
           deviated below the mean signal intensity of the remote myocardium on the T2* maps.

      Additional sequence for Day 3 and 7 CMR scans:

      â€¢ All the above plus MI size (measured in mass of LGE and expressed as a percentage of the LV
      mass).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>STEMI</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples will be collected from all participants.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting with an acute STEMI
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Confirmed STEMI as per PPCI procedure reports/ clinical notes

          2. Proximal to mid coronary artery occlusion.

          3. Ability to provide informed consent

        Exclusion Criteria:

          1. Previous myocardial infarction or coronary artery bypass graft surgery

          2. Contraindication for CMR (e.g. ferromagnetic implants, claustrophobia, estimated
             glomerular filtration rate &lt;30mL/min)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>National Heart Centre Singapore</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Heart Centre Singapore</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mung Peng</last_name>
    <phone>6704</phone>
    <phone_ext>2267</phone_ext>
    <email>wong.mung.peng@nhcs.com.sg</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Heart Centre Singapore</name>
      <address>
        <city>Singapore</city>
        <zip>169609</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mung Peng</last_name>
      <phone>6704</phone>
      <phone_ext>2267</phone_ext>
      <email>wong.mung.peng@nhcs.com.sg</email>
    </contact>
    <investigator>
      <last_name>Derek Hausenloy</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 31, 2016</study_first_submitted>
  <study_first_submitted_qc>May 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2016</study_first_posted>
  <last_update_submitted>May 31, 2016</last_update_submitted>
  <last_update_submitted_qc>May 31, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

